Kamada Reports Q4 EPS of $0.06, Revenue Misses Analyst Estimates
Reported by Reuters
Sentiment
Negative
Importance
7
Price
$8.6
Mkt Cap
$516.827M
52W Low
$5.54
52W High
$9.35
Market data snapshot near publication time
Summary
Kamada reported fourth-quarter earnings per share of $0.06 and net income of $3.6 million. The company's Q4 revenue came in at $44.7 million, falling short of the IBES estimate of $45.4 million. This revenue miss, while modest, could negatively impact investor sentiment and is a key metric for traders. Investors will now focus on any forward-looking statements or guidance provided by management regarding the company's outlook.
At the time of this announcement, KMDA was trading at $8.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $516.8M. The 52-week trading range was $5.54 to $9.35. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.
Price Chart
KMDA - Latest Insights
KMDA
Jun 01, 2026, 7:00 AM EDT
Price at Filing:
$7.91
Real-time Price:
$7.44
Change:
-$0.470 (-6%)
Market Cap:
$429.184M
KMDA
Jun 01, 2026, 7:00 AM EDT
Price at Filing:
$7.99
Real-time Price:
$7.44
Change:
-$0.550 (-7%)
Market Cap:
$429.184M
KMDA
May 13, 2026, 7:01 AM EDT
Price at Filing:
$8.40
Real-time Price:
$7.44
Change:
-$0.960 (-11%)
Market Cap:
$429.184M
KMDA
Mar 31, 2026, 7:00 AM EDT
Price at Filing:
$8.10
Real-time Price:
$7.44
Change:
-$0.660 (-8%)
Market Cap:
$429.184M
KMDA
Mar 26, 2026, 7:00 AM EDT
Price at Filing:
$8.28
Real-time Price:
$7.44
Change:
-$0.840 (-10%)
Market Cap:
$429.184M
KMDA
Mar 11, 2026, 7:24 AM EDT
Price at Filing:
$8.64
Real-time Price:
$7.44
Change:
-$1.20 (-14%)
Market Cap:
$429.184M
KMDA
Mar 11, 2026, 7:02 AM EDT
Price at Filing:
$8.60
Real-time Price:
$7.44
Change:
-$1.16 (-13%)
Market Cap:
$429.184M
KMDA
Jan 07, 2026, 7:00 AM EST
Price at Filing:
$7.78
Real-time Price:
$7.44
Change:
-$0.340 (-4%)
Market Cap:
$429.184M